Design, fabrication, and characterization of graft co-polymer assisted ocular insert: a state of art in reducing post-operative pain

References

• Sreenivas SA, Hiremath SP, Godbole AM. Ofloxacin ocular inserts: design, formulation and evaluation. Iran J Pharm Res. 2006;5(2):159–162.
   Google Scholar
• Chien YW. Ocular drug delivery and delivery systems; novel drug delivery systems. 2nd ed. New York: Marcel Dekker; 1996. p. 269–270.
   Google Scholar
• Ara T, Sharma S, Bhandari A. Preparation and evaluation of ocular inserts of diclofenac sodium for controlled drug delivery. Der Pharm. 2014;6(6):93–99.
   Google Scholar
• Jafariazar Z, Jamalinia N, Ghorbani-Bidkorbeh F, et al. Design and evaluation of ocular controlled delivery system for diclofenac sodium. Iran J Pharm Res. 2015;14:23–31.
   PubMed Web of Science ®Google Scholar
• Lee VH, Robinson JR Jr. Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol Ther. 1986;2:67–108.
   Google Scholar
• Hermans K, Van den Plas D, Kerimova S, et al. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. Int J Pharm. 2014;472:10–19.
   PubMed Web of Science ®Google Scholar
• Sultana Y, Aqil M, Ali A. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation. Acta Pharm. 2005;55:305–314.
   PubMedGoogle Scholar
• Baranowski P, Karolewicz B, Gajda M, et al. Ophthalmic drug dosage forms: characterization and research methods. Science. 2014;2014:1–14.
   Google Scholar
• Atram S, Bobade N. Current trends towards an ocular drug delivery system: review. Int J Pharm Pharm Sci. 2013;3(1):28–34.
   Google Scholar
• Karthikeyan D, Bhowmick M, Pandey V, et al. The concept of ocular inserts as drug delivery systems: an overview. Asian J Pharm. 2008;2:192–193.
   Google Scholar
• Attia M, Kassem M, Safwat S. In-vivo performance of 3H-dexamethasone ophthalmic film delivery systems in the rabbit eye. Int J Pharm. 1988;47:21–30.
   Web of Science ®Google Scholar
• Kumar S, Nagori B. Ocular insert: dosage form for sustain ophthalmic drug delivery. J Farm Klin Indones. 2012;1(2):61–73.
   Google Scholar
• Bade M, Gawali V. Ocular inserts: a rate controlled drug delivery system – a review. IJPE. 2012;2(1):49–63.
   Google Scholar
• Rajput G, Sharma S. Review on ophthalmic inserts. Int J Pharma Prof Res. 2013;4(3):912–920.
   Google Scholar
• Barath S, Hiremath S. Ocular delivery system of pefloxacin mesylate. Pharmazie. 1999;54:55–58.
   PubMed Web of Science ®Google Scholar
• Hume LR, Lee HK, Benedetti L, et al. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. Int J Pharm. 1994;111:295–298.
   Google Scholar
• Rathore K, Nema R. An insight into ophthalmic drug delivery system. Int J Pharm Sci Drug Res. 2009;1:1–5.
   Google Scholar
• Grass G, Cobby J, Makoid M. Ocular delivery of pilocarpine from erodible matrices. J Pharm Sci. 1984;73:618–621.
   PubMed Web of Science ®Google Scholar
• Maichuk Y. Ophthalmic drug inserts. Invest Ophthalmol Vis Sci. 1975;14:87–90.
   Google Scholar
• Ozawa H, Hosaka S, Kunitomo T, et al. Ocular inserts for controlled release of antibiotics. Biomaterials. 1983;4:170–174.
   PubMed Web of Science ®Google Scholar
• Kumari A, Sharma P, Garg V. Ocular insert: advancement in therapy of eye diseases. J Adv Pharm Technol Res. 2010;1(3):291–296.
   PubMedGoogle Scholar
• Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16:95–106.
   Web of Science ®Google Scholar
• Sampath Kumar K, Bhowmik D. Ocular inserts: a novel controlled drug delivery system. Pharma Innov J. 2013;1(12):1–16.
   Google Scholar
• Michael L, Collnot E-M, Djuric D, et al;al. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci. 2012;45:336–343.
   PubMed Web of Science ®Google Scholar
• Shamma R, Elkasabgy Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use. Drug Deliv. 2016;23(2):489–499.
   PubMed Web of Science ®Google Scholar
• Dian L, Yu E, Chen X, et al. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett. 2014;9:684.
   Web of Science ®Google Scholar
• Shamma RN, Basha M. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersion: formulation design and effect of method of preparation. Powder Technol. 2013;237:406–414.
   Web of Science ®Google Scholar
• Kim DH, Park MS, Choi Y, et al. Synthesis of PVA-g-POEM graft copolymers and their use in highly permeable thin composite membranes. Chem Eng J. 2018;346:739–747.
   Web of Science ®Google Scholar
• Available from: https://www.drugbank.ca/drugs/db06802
   Google Scholar
• Ahuja M, Dhake AS, Sharma SK, et al. Topical ocular delivery of NSAIDs. AAPS J. 2008;10(2):229–241.
   PubMed Web of Science ®Google Scholar
• Lane S. Nepafenac: a unique nonsteroidal prodrug. Int Ophthalmol Clin. 2006;46(4):13–20.
   PubMedGoogle Scholar
• Khurana G, Arora S, Pawar P. Ocular insert for sustained delivery of gatifloxacin sesquihydrate: preparation and evaluations. Int Pharm Investig. 2012;2(2):70–77.
   PubMedGoogle Scholar
• Agrawal A, Jadhav L. Ocular drug delivery system and role of ocular inserts in eye disorder treatment: a review. Asian J Pharm Technol Innov. 2016;4(21):45–54.
   Google Scholar
• Karathanos VT, Mourtzinos I, Yannakopoulou K, et al. Study of the solubility, antioxidant activity and structure of inclusion complex of vanillin with cyclodextrin. Food Chem. 2007;101:652–658.
   Web of Science ®Google Scholar
• Aburahma M, Mahmoud A. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in-vitro/in-vivo evaluation. AAPS PharmSciTech. 2011;12(4):1335–1347.
   PubMed Web of Science ®Google Scholar
• Dave V, Paliwal S, Yadav S. Formulation and evaluation of controlled delivery of aceclofenac through ocular insert. Turk J Pharm Sci. 2013;10(2):205–220.
   Google Scholar
• Mathurm M, Gilhotra RM. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E2-induced ocular inflammation. Drug Deliv. 2011;18(1):54–64.
   PubMed Web of Science ®Google Scholar
• Pandey A, Mali P. Design and in-vitro characterization of levobunolol hydrochloride ocuserts with special reference to glaucoma treatment. Indian J Pharm Educ Res. 2012;46(3):265–269.
   Web of Science ®Google Scholar
• Pandey P, Panwar A. Design and evaluation of ocular inserts for controlled drug delivery of acyclovir. Int J Pharm Biol Arch. 2011;2(4):1106–1110.
   Google Scholar
• Nappinnai M. Fluconazole ocular inserts: formulation and in-vitro evaluation. J Pharm Sci Res. 2010;2(6):344–350.
   Google Scholar
• Rajasekaran A, Sivakumar V. Design and evaluation of polymeric controlled release natamycin ocular inserts. Kathmandu Univ J Sci Eng Technol. 2010;6(1):108–115.
   Google Scholar
• Gandhi P, Rathod H, Patel S. A review on: ocular inserts a novel drug delivery system. Asian J Pharm Res Dev. 2013;1(1):40–48.
   Google Scholar
• Kaul S, Kumar G, Kothiyal P. An insight into ocular insert. Int J Pharm Sci Res. 2015;3:1–7.
   Google Scholar
• Gorle A, Gattani S. Development and evaluation of ocular drug delivery system. Pharm Dev Technol. 2010;15(1):46–52.
   PubMed Web of Science ®Google Scholar
• Damodharan N, Soundrapandian C. Ophthalmic inserts of piroxicam: development and in-vitro drug release studies. Asian J Chem. 2008;20(5):3447–3454.
   Google Scholar
• Ashture A, Kankudte A. Formulation and evaluation of controlled release ocular inserts of betaxolol hydrochloride; IOSR. J Pharm. 2012;2(5):34–38.
   Google Scholar
• Kothawade S, Deshpande S, Lunkad A. Formulation and in-vitro characterization of ketorolac tromethamine ophthalmic inserts. Res J Pharm Dosage Forms Tech. 2013;5(6):1–3.
   Google Scholar
• Ramkanth S, Chetty C. Design and evaluation of diclofenac sodium ocusert. Int J PharmTech Res. 2009;1(4):1219–1223.
   Google Scholar
• Patel D. In-vitro and in-vivo evaluation of ocular inserts of ofloxacin. DARU. 2007;15(3):138–145.
   Google Scholar
• Shafie M, Rady M. In-vitro and in-vivo evaluation of timolol maleate ocular inserts using different polymers. J Clin Exp Ophthalmol. 2012;3(8):1–9.
   Google Scholar
• Franca J, Foureaux G. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: in vitro and in vivo evaluation. PLoS One. 2014;9:1–14.
   Web of Science ®Google Scholar
• Paterakis PG, Korakianiti ES, Dallas PP, et al. Evaluation and simultaneous optimization of some pellet’s characteristics using 32 factorial design and the desirability function. Int J Pharm. 2002;248:51–60.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lafuente C, Furlanetto S, Fernandez-Arevalo M, et al. Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design. Int J Pharm. 2002;237:107–118.
   PubMed Web of Science ®Google Scholar
• Gadhave M, Pawar S. Formulation and evaluation of moxifloxacin ocusert. Int J Pharm Clin Res. 2016;8(12):1610–1615.
   Google Scholar
• Gevariya H, Dharamsi A, Girhepunje K, et al. Once a day ocular inserts for sustained delivery of levofloxacin: design, formulation and evaluation. Asian J Pharm. 2009;3:314–318.
   Google Scholar
• Morsi N, Ghorab D, Refai H, et al. Nanodispersion-loaded mucoadhesive polymeric inserts for prolonged treatment of post-operative ocular inflammation. J Microencapsul. 2017;34(3):280–292.
   PubMed Web of Science ®Google Scholar
• Mirzaeeia S, Alizadehc M. Design and evaluation of soluble ocular insert for controlled release of chloramphenicol. J Rep Pharm Sci. 2017;6(2):123–133.
   Google Scholar
• Indian Pharmacopoeia. Ministry of Health and Family Welfare. Government of India. Vol. 2. New Delhi: Controller of Publication; 1996. p. 117–147.
   Google Scholar
• Mundada A, Shrikhande B. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm. 2006;32:443–448.
   PubMed Web of Science ®Google Scholar
• Potu A, Reddy V. Design and evaluation of ocular inserts for controlled drug delivery of ketorolac tromethamine. World J Pharm Res. 2014;3(4):722–734.
   Google Scholar
• Gorle A, Gattani S. Design and evaluation of polymeric ocular drug delivery system. Chem Pharm Bull. 2009;57(9):914–919.
   PubMed Web of Science ®Google Scholar
• Sankar V, Chandrasekaran A. Design and evaluation of diclofenac sodium ocular inserts. Acta Pharm Sci. 2006;48:5–10.
   Google Scholar
• Michael H, Mostafa H, Mehdi J, et al. Draize rabbit eye test compatibility with eye irritation threshold in humans: a quantitative structural-activity relationship analysis. Toxicol Sci. 2003;76:384–391.
   PubMed Web of Science ®Google Scholar
• Kendre PN, Chaudhari PD. Effect of amphiphilic graft co-polymer-carrier on physical stability of bosentan nanocomposite: assessment of solubility, dissolution and bioavailability. Eur J Pharm Biopharm. 2018;126:177–186.
   PubMed Web of Science ®Google Scholar
• Kendre PN, Chaudhari PD. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets. Drug Dev Ind Pharm. 2017;43(5):751–761.
   PubMed Web of Science ®Google Scholar
• Kendre P, Chaudhari PD. Design and optimization of oral bioadhesive nanocurcumin delivery using novel hydrophilic carrier for cancer treatment: an alternative to parenteral chemotherapy. Indian Drugs. 2016;53:24–36.
   Google Scholar